Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lingzi Luo"'
Autor:
Ana A. Baumann, Jane S. Hankins, Lewis L. Hsu, Robert W. Gibson, Lynne D. Richardson, Marsha Treadwell, Jeffrey A. Glassberg, Sarah Bourne, Lingzi Luo, Rita V. Masese, Terri Demartino, Judith Nocek, Elizabeth Taaffe, Sierra Gollan, Ome-Ollin Ruiz, Chinonyelum Nwosu, Nai Qashou, Aimee S. James, Paula Tanabe, Allison A. King
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background This study aimed to capture the implementation process of the ALIGN Study, (An individualized Pain Plan with Patient and Provider Access for Emergency Department care of Sickle Cell Disease). ALIGN aimed to embed Individualized Pa
Externí odkaz:
https://doaj.org/article/906da8b1b27347609cce9d004dce8733
Autor:
Ana A. Baumann, Allison A. King, Cecelia Calhoun, Cole Hooley, Virginia R. McKay, Evelyn Shen, Anna Bauer, Lingzi Luo, Aimee S. James
Publikováno v:
J Pediatr Hematol Oncol
BACKGROUND: Sickle cell disease (SCD), an inherited red blood cell disorder, primarily affects African Americans in the United States. Adolescents and young adults with SCD (AYA-SCD) are at risk of high morbidity and mortality when transitioning from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77660e432425d2366c3ae3dc4dcc7545
https://doi.org/10.1097/mph.0000000000002322
https://doi.org/10.1097/mph.0000000000002322
Autor:
Catherine R. Hoyt, Jeni Erickson, Lingzi Luo, Taniya Varughese, Tara Han, Ashley J. Housten, Allison A. King
Publikováno v:
Journal of Early Intervention. :105381512311596
Background: Children with sickle cell disease (SCD), a genetic blood disorder, are at increased risk of developmental delays but are not routinely referred to Early Intervention (EI). The study aimed to understand the need for and acceptability and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b565482d4367a478dfc0c6b13f6d877
https://doi.org/10.1177/10538151231159637
https://doi.org/10.1177/10538151231159637
Autor:
Catherine R. Hoyt, Lingzi Luo, Allison J. L’Hotta, Natalie Haffner, Taniya Varughese, Jeni Erickson, Allison A. King, Lauren H. Yeager
Publikováno v:
Developmental medicine and child neurologyREFERENCES. 64(2)
AIM To summarize developmental delay among infants and toddlers with sickle cell disease (SCD). METHOD This systematic review included studies that reported developmental outcomes of children with SCD between 0 months and 48 months of age and followe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1404f03c951a0434ca38626f3820c2
https://pubmed.ncbi.nlm.nih.gov/34535892
https://pubmed.ncbi.nlm.nih.gov/34535892
Autor:
Huan Ye, Shaomei Huang, Cao-Yu Wang, Fei-Fei Cao, Lingzi Luo, Geng Zhang, Ying Zhou, Xingchang Lu, Jiangjiang Gu
Publikováno v:
Journal of Electroanalytical Chemistry. 835:178-185
Recently, the design of biomimetic enzymes based on ultrathin two-dimension (2D) metal-organic framework (MOF) nanosheets have attracted great attention due to their large surface area and abundant accessible active sites. In this work, ultrathin 2D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54b6b01262ed57a2eb95f4cf8e2905c7
https://doi.org/10.1016/j.jelechem.2019.01.030
https://doi.org/10.1016/j.jelechem.2019.01.030
Publikováno v:
The American Journal of Occupational Therapy. 76:7610510154p1-7610510154p1
Date Presented 04/01/2022 Around half of children with sickle cell disease (SCD) have a developmental delay by the age of 3, but developmental screening and intervention are not part of standard care. Through interviews with caregivers and early inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c30c7a1ed2fffe82c16e256ce2caa617
https://doi.org/10.5014/ajot.2022.76s1-po154
https://doi.org/10.5014/ajot.2022.76s1-po154
Autor:
Abdullah Kutlar, Marsha Treadwell, Matthew Lyon, Robert W. Gibson, Rachel L. Richesson, Lingzi Luo, Michael B. Potter, Janelle Armstrong-Brown, Ana A. Baumann, Donald Brambilla, Yvonne Carroll, Leslie S. Zun, Chris Carpenter, Lauren Siewny, Sarah Norell, Siera Gollan, Paula Tanabe, Greg A. Hall, Lynne D. Richardson, Gery W. Ryan, Martina Mueller, Lisa Cox, Allison A. King, Joseph Colla, Lisa M. Klesges, Cathy L. Melvin
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 4, p e24818 (2021)
JMIR Research Protocols
JMIR research protocols, vol 10, iss 4
JMIR Research Protocols
JMIR research protocols, vol 10, iss 4
Background Individuals living with sickle cell disease often require aggressive treatment of pain associated with vaso-occlusive episodes in the emergency department. Frequently, pain relief is poor. The 2014 National Heart, Lung, and Blood Institute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2f050663ec68a3054070add5a1b1f5
https://www.researchprotocols.org/2021/4/e24818
https://www.researchprotocols.org/2021/4/e24818
Autor:
Lingzi Luo, Allison A King, Yvonne Carroll, Ana A Baumann, Donald Brambilla, Christopher R Carpenter, Joseph Colla, Robert W Gibson, Siera Gollan, Greg Hall, Lisa Klesges, Abdullah Kutlar, Matthew Lyon, Cathy L Melvin, Sarah Norell, Martina Mueller, Michael B Potter, Rachel Richesson, Lynne D Richardson, Gery Ryan, Lauren Siewny, Marsha Treadwell, Leslie Zun, Janelle Armstrong-Brown, Lisa Cox, Paula Tanabe
BACKGROUND Individuals living with sickle cell disease often require aggressive treatment of pain associated with vaso-occlusive episodes in the emergency department. Frequently, pain relief is poor. The 2014 National Heart, Lung, and Blood Institute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5552a120cd1aab31da52304cb4092d59
https://doi.org/10.2196/preprints.24818
https://doi.org/10.2196/preprints.24818
Autor:
Sarah Norell, Marsha Treadwell, Cecelia Calhoun, Lingzi Luo, Shannon Phillips, Lucia Rojas Smith, Sherif M. Badawy, Hamda Khan, Jerlym S. Porter, Paula Tanabe, Chinonyelum Nwosu, Jason R. Hodges, Jane S. Hankins, Allison A. King
Publikováno v:
Blood Adv
Blood advances, vol 4, iss 18
Blood advances, vol 4, iss 18
Hydroxyurea is an efficacious treatment for sickle cell disease (SCD), but adoption is low among individuals with SCD. The objective of this study was to examine barriers to patients’ adherence to hydroxyurea use regimens by using the intentional a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce410dfba255d0f74231f1aa197a7409
https://pubmed.ncbi.nlm.nih.gov/33022064
https://pubmed.ncbi.nlm.nih.gov/33022064